Anti-retrovirals Flashcards

1
Q

In the treatment of HIV

a. indinavir prevents the synthesis of HIV DNA

A

A. False. Indinavir is a protease inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In the treatment of HIV

b. zidovudine is a protease inhibitor

A

B. False, zidovudine is nucleoside reverse transcriptase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In the treatment of HIV

c. lopinavir causes hyperlipidaemia as an adverse effect

A

C. True, PI cause insulin resistance, hyperglycaemia, diarrhea, dyslipidemia, lipodystrophy, atherosclerosis, hepatitis, osteoporosis, osteonecrosis as AEs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the treatment of HIV

d. zidovudine is more likely to cause anaemia than lamivudine

A

D. True. Zidovudine is the big one.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In the treatment of HIV

e. didanosine is used to treat stavudine-induced lactic acidosis

A

E. False, didanosine and stavudine greatly increase the risk of lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In the management of HIV

a. tenofovir is a HIV nucleotide reverse transcriptase enzyme inhibitor (NRTI)

A

A. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In the management of HIV

b. ritonavir causes inhibition of CYP3A4

A

B. True. Ritonavir is a potent inhibitor of CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In the management of HIV

c. lopinavir inhibits the action of HIV protease

A

C. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In the management of HIV

d. nevirapine inhibits DNA gyrase

A

D. False, nevirapine is a NNRTI and inhibits reverse transcriptase. Fluoroquinolones inhibit DNA gyrase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In the management of HIV

e. rifampicin increases the plasma levels of lopinavir

A

E. False, lopinavir is metabolised by CYP3A4 enzymes, which are induced by rifampicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lopinavir + ritonavir combination

a. inhibits HIV reverse transcriptase

A

A. False, PI inhibit HIV protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lopinavir + ritonavir combination

b. induces cytochrome P450 enzymes

A

B. False. The role of ritonavir in this combination is to act as a pharmacokinetic, enhancer, inhibiting CYP3A4 hence inhibit the metabolism of lopinavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lopinavir + ritonavir combination

c. causes insulin resistance as an adverse effect

A

C. True, PIs cause insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lopinavir + ritonavir combination

d. is a protease inhibitor

A

D. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lopinavir + ritonavir combination

e. causes lipodystrophy

A

E. True, Pis cause lipodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In the treatment of HIV

a. nevirapine is a direct inhibitor of reverse transcriptase

A

A. False, NNRTIs are indirect inhibitors of reverse transcriptase (allosteric inhibition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In the treatment of HIV

b. lamivudine causes peripheral neuropathy as an adverse effect

A

B. True, NRTIs cause peripheral neuropathy as an adverse effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

In the treatment of HIV

c. efavirenz requires phosphorylation to its active form

A

C. False, NNRTIs don’t require phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In the treatment of HIV

d. tenofivir is contraindicated in severe renal failure

A

D. True, tenofovir (TDF) causes nephrotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In the treatment of HIV

e. zidovudine is a cytosine analogue

A

E. False, thymidine analogue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In the treatment of HIV:

a. nevirapine is hepatotoxic

A

a. True. NNRTIs are hepatoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In the treatment of HIV:

b. efavirenz causes sleep disturbances

23
Q

In the treatment of HIV:

c. nevirapine increases the risk of Stevens Johnson syndrome

24
Q

In the treatment of HIV:

d. efavirenz is a nucleoside reverse transcriptase inhibitor

A

d. False, NNRTI

25
In the treatment of HIV: | e. nevirapine is used in combination with lamivudine as part of triple therapy
e. True, in neonates give Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP)
26
Lamivudine | a. is a non-nucleoside reverse transcriptase inhibitor
a. False. NRTI
27
Lamivudine | b. causes peripheral neuropathy as an adverse effect
b. True, NRTIs causes peripheral neuropathy
28
Lamivudine | c. is more toxic to the mitochondrion than zidovudine
c. False, zidovudine, didansoine and stavudine are the most toxic towards mitochondria. Mitochondrial toxicity is characterised by: peripheral neuropathy, pancreatitis, lipodystrophy syndrome, hepatic steatosis and myopathy
29
Lamivudine | d. is used in combination with emtricitabine
d. False, either Emtricitabine (FTC) or Lamivudine (3TC)
30
Lamivudine | e. has activity against Hepatitis B
e. True
31
Non-nucleoside reverse transcriptase inhibitors (NNRTI) | a. efivarenz is hepatotoxic
a. True
32
Non-nucleoside reverse transcriptase inhibitors (NNRTI) | b. efivarenz is safe to use in patients with schizophrenia
b. False, cause neurocognitive impairment
33
Non-nucleoside reverse transcriptase inhibitors (NNRTI) | c. nevirapine causes Stevens Johnson syndrome
c. True
34
Non-nucleoside reverse transcriptase inhibitors (NNRTI) | d. efivarenz induces cytochrome P450 enzymes
d. False, metabolised by CYP450 enzymes.
35
Non-nucleoside reverse transcriptase inhibitors (NNRTI) | e. efivarenz and nevirapine are combined as part of triple therapy in HIV
e. False, triple therapy includes 2 NRTIs + NNRTI/ Integrase inhibitor.
36
Tenofovir | a. is contraindicated in patients with advance kidney disease
a. True, nephrotoxic
37
Tenofovir | b. is used in combination with lamivudine as part of triple therapy in HIV
b. True
38
Tenofovir | c. compared to zidovudine, has a higher risk for causing lactic acidosis
c. False, both cause
39
Tenofovir | d. is a protease reverse transcriptase inhibitor
d. False, NRTI
40
Tenofovir | e. is a nucleotide anologue of adenosine
e. True
41
tenofovir is an HIV protease inhibitor
False, NRTI
42
lamivudine causes peripheral neuropathy as an adverse effect
True
43
zidovudine inhibits reverse transcriptase
True
44
nevirapine causes hepatotoxicity as an adverse effect
True
45
lopinavir decreases blood glucose levels
False | Increases
46
Antiretroviral agents | a. zidovudine inhibits reverse transcriptase
a. true, NRTI
47
Antiretroviral agents | b. nevirapine prevents the synthesis of viral DNA
b. true, NNRTI
48
Antiretroviral agents | c. efavirenz is contraindicated during pregnancy
c. False, indicated, dolutegravir is risky
49
3. In the management of HIV | a. tenofovir is a HIV nucleotide reverse transcriptase enzyme inhibitor (NRTI)
a. True
50
In the management of HIV | b. ritonavir causes inhibition of CYP3A4
b. True
51
In the management of HIV | c. lopinavir inhibits the action of HIV protease
c. True
52
In the management of HIV | d. nevirapine inhibits DNA gyrase
d. False, NNRTI
53
In the management of HIV | e rifampicin increases the plasma levels of lopinavir
e. False, induces p450 enzymes